At a glance
ClinicalIndex Comparison RecordN/ACompleted· 225 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic Gastrointestinal Disorders (IBS, IBD, CRC)
In Brief
An observational study for Irritable Bowel Syndrome and 3 related conditions. Completed, enrolled 225 participants across 1 site.
Detailed Summary
This clinical trial hypothesize that Gut Microbiota (bacteria, viruses, fungi)play a major role in the occurrence and progression of many chronic gastrointestinal diseases like Irritable Bowel Syndrome, Inflammatory Bowel Diseases and Colo-Rectal Cancer. Hence, aims to study the spectrum of such microbiota in these patients as compared to normal subjects, by utilizing metagenomic techniques rather than cultural methods.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSaudi Arabia
CollaboratorsKing AbdulAziz City for Science and Technology
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartJul 2010
Primary CompletionJan 2012
Study CompletionMar 2012
TodayJul 2026
First PostedApr 6, 2010
Enrollment StartJul 1, 2010
Primary CompletionJan 1, 2012
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 16.2 years ago